Back to Market Feed

Product Information

EMTRIVA 200 MG CAPSULE is a brand product labeled by Gilead Sciences, Inc., priced at $17.4459 per EA under NDC 61958060101. Its NADAC has been published 527 times since Nov 28, 2013.

FDA first approved this application on Jul 2, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

EMTRIVA 200 MG CAPSULE

EMTRICITABINE
$17.4459per EA

Strength

200 mg/1

NDC

61958060101

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Effective Date

7/22/2026

Active Ingredients

EMTRICITABINE

Approval Type

New Drug (NDA)

FDA Application

NDA021500

FDA Approved

7/2/2003

TE Code

AB

On Market Since

7/2/2003

Pharmacological Classes

Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Reverse Transcriptase Inhibitors
Nucleosides

Price Statistics

The NADAC for EMTRIVA 200 MG CAPSULE has been published 527 times since Nov 28, 2013, and over the history we have for it it has risen 13.3%. The table below summarizes its recorded NADAC range and movement.

Current price$17.4459 per EA
All-time high$17.7567 (Jan 11, 2017)
All-time low$15.3525 (Dec 18, 2013)
52-week high$17.4459
52-week low$17.4267
Median price$17.3547
Average price$17.1715
Largest weekly change+6.9% (Apr 8, 2015)
Weeks tracked527
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

+0.1%

6M

+0.1%

1Y

+0.1%

3Y

+0.1%

5Y

+0.1%

All

+13.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the EMTRICITABINE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

EPIVIR 10 MG/ML ORAL SOLN
Brand
49702020548•ViiV Healthcare Company
$0.4452
per ML
ZIAGEN 20 MG/ML SOLUTION
Brand
49702022248•ViiV Healthcare Company
$0.5865
per ML
EPIVIR 150 MG TABLET
Brand
49702020318•ViiV Healthcare Company
$6.6144
per EA
IMURAN 50 MG TABLET
Brand
54766059010•Sebela Pharmaceuticals Inc.
$8.8907
per EA
INTELENCE 100 MG TABLET
Brand
59676057001•Janssen Products LP
$10.9213
per EA
EPIVIR 300 MG TABLET
Brand
49702020413•ViiV Healthcare Company
$13.2940
per EA
COMBIVIR TABLET
Brand
49702020218•ViiV Healthcare Company
$14.3948
per EA
INTELENCE 200 MG TABLET
Brand
59676057101•Janssen Products LP
$24.3032
per EA
VIREAD 300 MG TABLET
Brand
61958040101•Gilead Sciences, Inc.
$40.7283
per EA
BARACLUDE 1 MG TABLET
Brand
00003161212•E.R. Squibb & Sons, L.L.C.
$43.9221
per EA

Frequently asked questions

What is the NADAC price of EMTRIVA 200 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for EMTRIVA 200 MG CAPSULE, manufactured by Gilead Sciences, Inc., is $17.4459 per EA (NDC 61958060101), effective Aug 19, 2026.

How has the price of EMTRIVA 200 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for EMTRIVA 200 MG CAPSULE has risen 13.3%. It has been tracked across 527 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for EMTRIVA 200 MG CAPSULE?

Since Nov 28, 2013, the NADAC for EMTRIVA 200 MG CAPSULE has ranged from a low of $15.3525 (Dec 18, 2013) to a high of $17.7567 (Jan 11, 2017), with a median of $17.3547 per EA.

Are there cheaper alternatives to EMTRIVA 200 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of EMTRIVA 200 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures EMTRIVA 200 MG CAPSULE?

EMTRIVA 200 MG CAPSULE (NDC 61958060101) is labeled by Gilead Sciences, Inc., and CMS classifies it as a brand product.